Practice Patterns and Training Needs Among Physicians Certifying Patients for Medical Marijuana in Florida.


Journal

Journal of primary care & community health
ISSN: 2150-1327
Titre abrégé: J Prim Care Community Health
Pays: United States
ID NLM: 101518419

Informations de publication

Date de publication:
Historique:
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 21 10 2021
Statut: ppublish

Résumé

Little is known about the clinical training or practice experiences among physicians who certify patients for medical marijuana. The objective of this study was to determine information sources, factors influencing recommendations, clinical practices in patient assessment, communications, and recommendations, and priority areas for additional training among physicians who certify patients for medical marijuana. A cross-sectional state-wide anonymous survey of registered medical marijuana physicians in Florida between June and October 2020 was administered. Numerical responses were quantified using counts and percentages. The frequencies for "often" and "always" responses were aggregated when appropriate. Among 116 respondents, the mean (standard deviation) age was 57 (12) years old, and 70% were male. The most frequently used information sources were research articles (n = 102, 95%), followed by online sources (n = 99, 93%), and discussions with other providers and dispensary staff (n = 84, 90%). Safety concerns were most influential in patient recommendations (n = 39, 39%), followed by specific conditions (n = 30, 30%) and patient preferences (n = 26, 30%). Ninety-three physicians (92%) reported they "often" or "always" perform a patient physical exam. Eighty-four (77%) physicians provided specific administration route recommendations. Half (n = 56) "often" or "always" provided specific recommendations for Δ-9-tetrahydrocannabinol: cannabidiol ratios, while 69 (62%) "often" or "always" provided specific dose recommendations. Online learning/training modules were the most preferred future training mode, with 88 (84%) physicians "likely" or "very likely" to participate. The top 3 desired topics for future training were marijuana-drug interactions (n = 84, 72%), management of specific medical conditions or symptoms (n = 83, 72%), and strategies to reduce opioids or other drugs use (n = 78, 67%). This survey of over 100 medical marijuana physicians indicates that their clinical practices rely on a blend of research and anecdotal information sources. While physicians report clinical factors as influential during patient recommendation, patient assessment practices and treatment regimen recommendations vary substantially and rely on experimental approaches. More research is needed to inform evidence-based practice and training, especially considering details on drug interactions, risk-benefit of treatment for specific clinical conditions, and strategies to reduce opioid use.

Sections du résumé

BACKGROUND
Little is known about the clinical training or practice experiences among physicians who certify patients for medical marijuana. The objective of this study was to determine information sources, factors influencing recommendations, clinical practices in patient assessment, communications, and recommendations, and priority areas for additional training among physicians who certify patients for medical marijuana.
METHODS
A cross-sectional state-wide anonymous survey of registered medical marijuana physicians in Florida between June and October 2020 was administered. Numerical responses were quantified using counts and percentages. The frequencies for "often" and "always" responses were aggregated when appropriate.
RESULTS
Among 116 respondents, the mean (standard deviation) age was 57 (12) years old, and 70% were male. The most frequently used information sources were research articles (n = 102, 95%), followed by online sources (n = 99, 93%), and discussions with other providers and dispensary staff (n = 84, 90%). Safety concerns were most influential in patient recommendations (n = 39, 39%), followed by specific conditions (n = 30, 30%) and patient preferences (n = 26, 30%). Ninety-three physicians (92%) reported they "often" or "always" perform a patient physical exam. Eighty-four (77%) physicians provided specific administration route recommendations. Half (n = 56) "often" or "always" provided specific recommendations for Δ-9-tetrahydrocannabinol: cannabidiol ratios, while 69 (62%) "often" or "always" provided specific dose recommendations. Online learning/training modules were the most preferred future training mode, with 88 (84%) physicians "likely" or "very likely" to participate. The top 3 desired topics for future training were marijuana-drug interactions (n = 84, 72%), management of specific medical conditions or symptoms (n = 83, 72%), and strategies to reduce opioids or other drugs use (n = 78, 67%).
CONCLUSIONS
This survey of over 100 medical marijuana physicians indicates that their clinical practices rely on a blend of research and anecdotal information sources. While physicians report clinical factors as influential during patient recommendation, patient assessment practices and treatment regimen recommendations vary substantially and rely on experimental approaches. More research is needed to inform evidence-based practice and training, especially considering details on drug interactions, risk-benefit of treatment for specific clinical conditions, and strategies to reduce opioid use.

Identifiants

pubmed: 34452585
doi: 10.1177/21501327211042790
pmc: PMC8404623
doi:

Substances chimiques

Analgesics, Opioid 0
Medical Marijuana 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21501327211042790

Références

Medicines (Basel). 2018 Dec 23;6(1):
pubmed: 30583596
CMAJ. 2014 Jun 10;186(9):657
pubmed: 24799559
Cannabis Cannabinoid Res. 2018 Mar 01;3(1):74-84
pubmed: 29662957
J Am Board Fam Med. 2018 Sep-Oct;31(5):805-808
pubmed: 30201677
J Appl Oral Sci. 2011 Oct;19(5):
pubmed: 21986662
BMC Fam Pract. 2019 Jan 22;20(1):17
pubmed: 30669979
Mayo Clin Proc. 2017 Mar;92(3):423-433
pubmed: 28259229
Med Care. 1999 Apr;37(4):333-8
pubmed: 10213014
Nat Rev Cardiol. 2018 Mar;15(3):151-166
pubmed: 28905873
Ther Adv Psychopharmacol. 2012 Dec;2(6):241-54
pubmed: 23983983
Sci Rep. 2018 Mar 14;8(1):4519
pubmed: 29540728
Drug Alcohol Depend. 2017 Nov 1;180:151-155
pubmed: 28892720
P T. 2017 Mar;42(3):180-188
pubmed: 28250701
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Am J Psychiatry. 2012 Jun;169(6):564-8
pubmed: 22684592
Ann Intern Med. 2011 Jun 7;154(11):752-7
pubmed: 21646558
Mo Med. 2019 Mar-Apr;116(2):146-153
pubmed: 31040502
Addict Behav. 2017 Sep;72:1-7
pubmed: 28319813
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719831871
pubmed: 30795717
CMAJ. 2020 Mar 2;192(9):E206
pubmed: 32122975

Auteurs

Ruba Sajdeya (R)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

Anna Shavers (A)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

Jennifer Jean-Jacques (J)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

Brianna Costales (B)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

Sebastian Jugl (S)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

Carly Crump (C)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

Yan Wang (Y)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

Luran Manfio (L)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

R Nathan Pipitone (RN)

Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.
Florida Gulf Coast University, Fort Myers, FL, USA.

Martha S Rosenthal (MS)

Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.
Florida Gulf Coast University, Fort Myers, FL, USA.

Almut G Winterstein (AG)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

Robert L Cook (RL)

University of Florida, Gainesville, FL, USA.
Consortium for Medical Marijuana Clinical Outcomes Research, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH